Developing an Ideal First Use Agent to Prevent Sepsis in Trauma Wounds During Care Under Fire
Award amount
$111,480Program and phase
SBIR · Phase IAward year
2021Award details
- Awarding agency
- Department of Defense
- Branch
- Army
- Recipient company
- ALTRAZEAL LIFE SCIENCES INC
- Proposal award date
- 2020-10-08
- Contract end date
- 2021-11-25
- UEI
- N24WUMUHT5V9
- Solicitation number
- 20.2
- Topic code
- A20-137
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Innovative and Adaptive Drug Delivery System for Enhanced Neuroprotection and Repair in Traumatic Brain Injuries from Penetrating Trauma or Open Skull Fractures in Low Resource Environments
- Developing an Ideal First Use Agent to Prevent Sepsis in Trauma Wounds During Care Under Fire
- Developing an Ideal First Use Agent to Prevent Sepsis in Trauma Wounds During Care Under Fire
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Succor Combat Foam for Advanced Wound Care of Traumatized Tissue
- Succor Combat Foam for Advanced Wound Care of Traumatized Tissue
- Succor Combat Foam for Advanced Wound Care of Traumatized Tissue
Research funding history
4 SBIR/STTR records share this UEI (2021–2025). Reported award amounts total $3,867,447. Reported amounts are not federal obligations.
Phases: Phase II, Phase I
Agencies: Department of Defense